おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Confluence Pharmaceuticals
company
About
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $200K
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$200K
Confluence Pharmaceuticals has raised a total of
$200K
in funding over 2 rounds. Their latest funding was raised on
Apr 12, 2019 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 12, 2019 | Series Unknown | $200K | 1 |
Indiana University Philanthropic Venture Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Confluence Pharmaceuticals is funded by 1 investors.
Indiana University Philanthropic Venture Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Indiana University Philanthropic Venture Fund
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
